Document is current
Any future updates will be listed below
-
Authors
Alzubi, Mohammad A. https://orcid.org/0000-0002-3953-8436
Barberi, Theresa https://orcid.org/0000-0002-7816-1969
Friedman, Alan D. https://orcid.org/0000-0002-5615-7061
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32 CA060441, P30 CA006973, P30 CA006973)
Department of Defense Prostate Cancer Research Program (W81XWH-21-1-0671)
- License Information
-
More Information
Article History
Received: 30 January 2024
Accepted: 30 December 2024
First Online: 4 February 2025
Declarations
:
: ADF is a named inventor on PCT applications entitled “NF-κB p50 Deficient Immature Myeloid Cells and Their Use in Treatment of Cancer” and “Prostate-Specific Membrane Antigen Targeted NF-κB p50-Deficient Immature Myeloid Cells” filed by the Johns Hopkins University. MAZ and TB declare that they have no financial interests.
: This work was conducted in accordance with the Guide for the Care and Use of Laboratory Animals and was approved the Johns Hopkins Animal Care and Use Committee.
